Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 05 - 03 tags : Clinical-trials-phase-iii save search
Arcutis to Present New Roflumilast Cream Phase 3 Data at The European Academy of Dermatology and Venereology (EADV) Spring Symposium
Published: 2021-05-03 (Crawled : 21:00) - biospace.com/
ARQT | $8.94 -1.76% -1.9% 1M
|
Health Technology
|
| O: 5.31%
H: 0.6%
C: -1.5%
europe phase 3 symposium
Zealand Pharma announces publication of Phase 3 trial evaluating efficacy and safety of dasiglucagon for treatment of severe hypoglycemia in adult patients with diabetes
Published: 2021-05-03 (Crawled : 18:00) - biospace.com/
ZEAL | $17.59 1.21% -4.21%
|
Health Technology
|
| O: 0.55%
H: 1.25%
C: -0.69%
diabetes treatment hypoglycemia phase 3 trial
Galmed Announces Approval of IND Application in China for Aramchol for the Treatment of NASH & Fibrosis in the Global Phase 3 ARMOR Registrational Study
Published: 2021-05-03 (Crawled : 14:00) - biospace.com/
GLMD | $0.3641 -2.33% -0.41% 64K
|
Health Technology
|
| O: 1.23%
H: 3.55%
C: -0.91%
treatment fibrosis china phase 3 nash approval application aramchol
Eiger BioPharmaceuticals Announces Peginterferon Lambda to be Added to Multi-Center Phase 3 TOGETHER COVID-19 Study in Brazil
Published: 2021-05-03 (Crawled : 13:00) - biospace.com/
EIGR | $1.725 -1.45% 140K
|
Health Technology
|
| O: 0.82%
H: 5.78%
C: 1.4%
covid biopharma brazil phase 3
Alnylam Announces Positive Early Results on Clinical Outcome Measures from ILLUMINATE-A Phase 3 Study of OXLUMO® (lumasiran)
Published: 2021-05-03 (Crawled : 12:00) - biospace.com/
SNY | News | $47.15 1.84% 1.75% 2M
|
Health Technology
|
| O: -4.18%
H: 1.62%
C: 1.41%
ALNY | $145.79 0.96% 0.94% 400K
|
Health Technology
|
| O: -0.11%
H: 0.09%
C: -3.66%
positive results phase 3
Gainers vs Losers
| 74% | 26% |
Top 10 Gainers
MTTR | News M | $4.8 175.86% 63.6% 71M
|
AGBA | $2.5 100.0% 56.6% 200M
|
Finance
MLEC | $2.47 76.43% 42.62% 78M
|
n/a
NUWE | $0.334 29.96% 40.99% 2.5M
|
Manufacturing
EDBL | News | $6.26 66.49% 40.13% 16M
|
ATGL | $2.86 46.25% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6088 38.68% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.7M
|
Your saved searches
Save your searches and get alerts when important news are released.